Naomi Pacalin
InvestorAssociate, Private Equity at Sofinnova Ventures
About
Naomi Pacalin joined Sofinnova as an Analyst and became an Associate in 2025, where she works on biopharmaceutical company investments across multiple disease areas and therapeutic modalities. She holds a PhD in Bioengineering from Stanford University, where her research in Howard Chang's lab covered epigenomics and gene regulation using CRISPR epigenetic editing and single-cell sequencing. She also earned a BS in Biological Chemistry and a BA in Chemistry from the University of Chicago, and previously served as a Sofinnova Venture Fellow.
Contact· self-published, not guessed
Invests in
Biotech
Colleagues at Sofinnova Ventures
Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures
Frequently asked questions
- Who is Naomi Pacalin?
- Naomi Pacalin joined Sofinnova as an Analyst and became an Associate in 2025, where she works on biopharmaceutical company investments across multiple disease areas and therapeutic modalities. She holds a PhD in Bioengineering from Stanford University, where her research in Howard Chang's lab covered epigenomics and gene regulation using CRISPR epigenetic editing and single-cell sequencing. She also earned a BS in Biological Chemistry and a BA in Chemistry from the University of Chicago, and previously served as a Sofinnova Venture Fellow.
- Where does Naomi Pacalin work?
- Naomi Pacalin is Associate, Private Equity at Sofinnova Ventures.
- What does Naomi Pacalin invest in?
- Naomi Pacalin invests in Biotech.